Log In
BCIQ
Print this Print this
 

NAL2762

  Manage Alerts
Collapse Summary General Information
Company NAL Pharmaceuticals Ltd.
DescriptionNicotine orally dissolving film
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationAddiction
Indication DetailsTreat nicotine addiction
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today